secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neptune Wellness Solutions Inc. (—)
CIK:        0001401395
Form:       8-K
Filed at:   2023-11-24T23:59:59+00:00
Accession:  0001437749-23-032991
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neptune subsidiary Biodroga enters $3M accounts receivable and inventory financing with Alterna Capital
--------------------------------------------------------------------------------

- Biodroga sold eligible accounts receivable to Alterna Capital Solutions; initial max amount $3M, can increase to $8M.
- Inventory Finance Rider provides advances up to 75% of eligible inventory value at lower of cost or market.
- Fees include prime plus 1% (min 9.5% per annum) on funds used; $20 per wire and other customary costs.
- Initial 12-month term with automatic annual renewal; parent Neptune provided a Commercial Guaranty.
- Collateral includes accounts receivable and inventory; security interest granted to Alterna.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401395/000143774923032991/0001437749-23-032991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401395/000143774923032991/nept20231124_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-032991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer